A detailed history of Rakuten Securities, Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Rakuten Securities, Inc. holds 60 shares of UTHR stock, worth $21,450. This represents 0.01% of its overall portfolio holdings.

Number of Shares
60
Previous 10 500.0%
Holding current value
$21,450
Previous $3.58 Million 490.68%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$348.66 - $410.0 $17,433 - $20,500
50 Added 500.0%
60 $21.2 Million
Q3 2024

Nov 05, 2024

SELL
$311.04 - $363.55 $4,354 - $5,089
-14 Reduced 58.33%
10 $3.58 Million
Q2 2024

Jul 31, 2024

BUY
$228.26 - $319.04 $3,880 - $5,423
17 Added 242.86%
24 $7.65 Million
Q1 2024

May 01, 2024

SELL
$210.76 - $249.51 $13,277 - $15,719
-63 Reduced 90.0%
7 $1.61 Million
Q4 2023

Jan 30, 2024

BUY
$214.88 - $256.94 $15,041 - $17,985
70 New
70 $15.4 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.3B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Rakuten Securities, Inc. Portfolio

Follow Rakuten Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rakuten Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Rakuten Securities, Inc. with notifications on news.